Chapter 1. Methodology and Scope
1.1. Information Procurement
1.1.1. Purchased database:
1.1.1.1. nova one advisor internal database
1.1.2. Market Formulation & Validation
1.2. Research Methodology
1.3. Research Scope and Assumptions
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
2.4. U.S. Telehealth Market Snapshot
Chapter 3. U.S. Telehealth Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Industry Challenge
3.3. U.S. Telehealth Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.4. Impact of COVID 19 on U.S. Telehealth Market
Chapter 4. U.S. Telehealth Market: Product Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Telehealth Market: Product Type Movement Analysis, , 2024 - 2033
4.2.1. Hardware
4.2.1.1. Hardware Market Estimates And Forecasts, 2021 - 2033
4.2.1.1.1. Monitor
4.2.1.1.1.1. Monitor Market Estimates And Forecasts, 2021 - 2033
4.2.1.1.2. Medical Peripheral Devices
4.2.1.1.2.1. Medical Peripheral Devices Market Estimates And Forecasts, 2021 - 2033
4.2.1.1.2.2. Blood Pressure Meters
4.2.1.1.2.2.1. Blood Pressure Meters Market Estimates And Forecasts, 2021 - 2033
4.2.1.1.2.3. Blood Glucose Meters
4.2.1.1.2.3.1. Blood Glucose Meters Market Estimates And Forecasts, 2021 - 2033
4.2.1.1.2.4. Weighing Scales
4.2.1.1.2.4.1. Weighing Scales Market Estimates And Forecasts, 2021 - 2033
4.2.1.1.2.5. Pulse Oximeter
4.2.1.1.2.5.1. Pulse Oximeter Market Estimates And Forecasts, 2021 - 2033
4.2.1.1.2.6. Peak Flow Meters
4.2.1.1.2.6.1. Peak Flow Meters Market Estimates And Forecasts, 2021 - 2033
4.2.1.1.2.7. ECG Monitors
4.2.1.1.2.7.1. ECG Monitors Market Estimates And Forecasts, 2021 - 2033
4.2.1.1.2.8. Others
4.2.1.1.2.8.1. Others Market Estimates And Forecasts, 2021 - 2033
4.2.2. Software
4.2.2.1. Software Market Estimates And Forecasts, 2021 - 2033
4.2.2.1.1. Standalone Software
4.2.2.1.1.1. Standalone Software Market Estimates And Forecasts, 2021 - 2033
4.2.2.1.2. Integrated Software
4.2.2.1.2.1. Integrated Software Market Estimates And Forecasts, 2021 - 2033
4.2.3. Services
4.2.3.1. Services Market Estimates And Forecasts, 2021 - 2033
4.2.3.1.1. Remote Patient Monitoring
4.2.3.1.1.1. Remote Patient Monitoring Market Estimates And Forecasts, 2021 - 2033
4.2.3.1.2. Real-time Interactions
4.2.3.1.2.1. Real-time Interactions Market Estimates And Forecasts, 2021 - 2033
4.2.3.1.3. Store and Forward
4.2.3.1.3.1. Store and Forward Market Estimates And Forecasts, 2021 - 2033
4.2.3.1.4. Others
4.2.3.1.4.1. Others Market Estimates And Forecasts, 2021 - 2033
Chapter 5. U.S. Telehealth Market: Delivery Mode Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. Telehealth Market: Delivery Mode Movement Analysis, , 2024 - 2033
5.2.1. Web-based
5.2.1.1. Web-based Market Estimates And Forecasts, 2021 - 2033
5.2.2. Cloud-based
5.2.2.1. Cloud-based Market Estimates And Forecasts, 2021 - 2033
5.2.3. On-premises
5.2.3.1. On-premises Market Estimates And Forecasts, 2021 - 2033
Chapter 6. U.S. Telehealth Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. U.S. Telehealth Market: End Use Movement Analysis, , 2024 - 2033
6.2.1. Providers
6.2.1.1. Providers Market Estimates And Forecasts, 2021 - 2033
6.2.2. Payers
6.2.2.1. Payers Market Estimates And Forecasts, 2021 - 2033
6.2.3. Patients
6.2.3.1. Patients Market Estimates And Forecasts, 2021 - 2033
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Key Company Market Position Analysis
7.3. Key Company Market Share Analysis
7.4. Recent Development and Impact Analysis, by key Market Participants
7.5. Company Profiles
7.5.1. Koninklijke Philips N.V
7.5.1.1. Company Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic initiatives
7.5.2. GE Healthcare
7.5.2.1. Company Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic initiatives
7.5.3. Cerner
7.5.3.1. Company Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic initiatives
7.5.4. Siemens Healthineers
7.5.4.1. Company Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic initiatives
7.5.5. Medtronic
7.5.5.1. Company Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic initiatives
7.5.6. Teladoc Health Inc.
7.5.6.1. Company Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic initiatives
7.5.7. American Well
7.5.7.1. Company Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic initiatives
7.5.8. MD Live
7.5.8.1. Company Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic initiatives
7.5.9. Doctor in Demand
7.5.9.1. Company Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic initiatives
7.5.10. U.S. Med
7.5.10.1. Company Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic initiatives
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers